> Over time, Big Pharma learned how to game the law. As the patent for the original drug approached expiration, companies added wrinkles — a new coating for the pill, a time-release version, and so on — that they then patented. If the patents were approved, and they usually were, the exclusivity clock would start ticking all over again.
I don't understand how that would ever work.
Time-release version of X, now with new coating: patented
Old version of X, with no time-release and without new coating: patented expired, correct?
If so, what stops the generic manufacturer from just manufacturing the old version of X?